Summary:
- This article discusses a partnership between Science 37 and Catalent, two companies in the healthcare and pharmaceutical industry.
- The partnership aims to enable universal access to clinical research by leveraging Science 37's decentralized clinical trial platform and Catalent's expertise in drug development and manufacturing.
- This collaboration is expected to streamline the clinical trial process, making it more accessible and inclusive for participants, ultimately leading to faster and more efficient drug development.